Neuroinflammatory Cytokines—The Common Thread in Alzheimer Pathogenesis
Alzheimer’s disease in a Chinese population, Neurosci Lett, 2003;343:93–6.
140. Déniz-Naranjo MC, Muñoz-Fernandez C, Alemany-Rodriguez MJ, et al., Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain, Eur J Neurol, 2008;15:1080–4.
141. Di Bona D, Plaia A, Vasto S, et al., Association between the interleukin-1beta polymorphisms and Alzheimer’s disease: a systematic review and meta-analysis, Brain Res Rev, 2008;59:155–63.
142. Klimkowicz-Mrowiec A, Marona M, Wolkow P, et al., Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer’s disease in a Polish population, Dement Geriatr Cogn Disord, 2009;28:461–4.
143. Ravaglia G, Paola F, Maioli F, et al., Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study, Exp Gerontol, 2006;41:85–92.
144. Rainero I, Bo M, Ferrero M, et al., Association between the interleukin-1alpha gene and Alzheimer’s disease: a meta-analysis, Neurobiol Aging, 2004;25:1293–8.
145. Combarros O, Llorca J, Sanchez-Guerra M, et al., Age-dependent association between interleukin-1A (-889) genetic polymorphism and sporadic Alzheimer’s disease. A meta-analysis, J Neurol, 2003;250:987–9.
146. Combarros O, Sanchez-Guerra M, Infante J, et al., Gene dose-dependent association of interleukin-1A -889] allele 2 polymorphism with Alzheimer’s disease, J Neurol, 2002;249:1242–5.
147. Yucesoy B, Peila R, White LR, et al., Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study, Neurobiol Aging, 2006;27:211–7.
148. Bertram L, McQueen MB, Mullin K, et al., Systematic meta- analyses of Alzheimer disease genetic association studies: the AlzGene database, Nat Genet, 2007;39:17–23.
149. Ribizzi G, Fiordoro S, Barocci S, et al., Cytokine polymorphisms and Alzheimer disease: possible associations, Neurol Sci, 2010;31:321–5.
150. Du Y, Dodel RC, Eastwood BJ, et al., Association of an interleukin 1 alpha polymorphism with Alzheimer’s disease, Neurology, 2000;55:480–3.
151. Hedley R, Hallmayer J, Groth DM, et al., Association of interleukin-1 polymorphisms with Alzheimer’s disease in Australia, Ann Neurol, 2002;51:795–7.
152. Mrak RE, Griffin WS, Glia and their cytokines in progression of neurodegeneration, Neurobiol Aging,
2005;26:349–54.
153. Mackenzie IR, Senile plaques do not progressively accumulate with normal aging, Acta Neuropathol (Berl), 1994;87:520–5.
154. Sperling RA, Laviolette PS, O’Keefe K, et al., Amyloid deposition is associated with impaired default network function in older persons without dementia, Neuron, 2009;63:178–88.
155. Mackenzie IR, Hao C, Munoz DG, Role of microglia in senile plaque formation, Neurobiol Aging, 1995;16:797–804.
156. Sheng JG, Mrak RE, Rovnaghi CR, et al., Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer’s disease, Neurobiol Aging, 1996;17:359–63.
157. Sheng JG, Mrak RE, Griffin WS, Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain, Acta Neuropathol,1998;95:229–34.
158. Gouras GK, Relkin NR, Sweeney D, et al., Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques, Ann Neurol, 1997;41:402–4.
159. Teasdale GM, Murray GD, Nicoll JA, The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study, Brain, 2005;128:2556–61.
160. Sparks DL, Hunsaker JC, 3rd, Scheff SW, et al., Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease, Neurobiol Aging, 1990;11:601–7.
161. Esiri MM, Biddolph SC, Morris CS, Prevalence of Alzheimer plaques in AIDS, J Neurol Neurosurg Psychiatry, 1998;65:29–33.
162. Stanley LC, Mrak RE, Woody RC, et al., Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer’s disease, J Neuropathol Exp Neurol, 1994;53:231–8.
163. Biessels GJ, Staekenborg S, Brunner E, et al., Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, 2006;5:64–74.
164. Dore GA, Elias MF, Robbins MA, et al., Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study, Diabetologia, 2009;52(12):2551–60.
165. Xu WL, von Strauss E, Qiu CX, et al., Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population- based cohort study, Diabetologia, 2009;52:1031–9.
166. Kloppenborg RP, van den Berg E, Kappelle LJ, et al., Diabetes and other vascular risk factors for dementia:
which factor matters most? A systematic review, Eur J Pharmacol, 2008;585:97–108.
167. van den Berg E, Kloppenborg RP, Kessels RP, et al., Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition, Biochim Biophys Acta, 2009;1792:470–81.
168. Xu WL, Qiu CX, Wahlin A, et al., Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study, Neurology, 2004;63:1181–6.
169. Yoshitake T, Kiyohara Y, Kato I, et al., Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study, Neurology, 1995;45:1161–8.
170. Peila R, White LR, Petrovich H, et al., Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study, Stroke, 2001;32:2882–9.
171. Peila R, Rodriguez BL, Launer LJ, Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study, Diabetes, 2002;51:1256–62.
172. Griffin WS, Sheng JG, Gentleman SM, et al., Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression, Neurosci Lett, 1994;176:133–6.
173. Gentleman SM, Leclercq PD, Moyes L, et al., Long-term intracerebral inflammatory response after traumatic brain injury, Forensic Sci Int, 2004;146:97–104.
174. Graham DI, Gentleman SM, Nicoll JA, et al., Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer’s disease, Acta Neurochir Suppl, 1996;66:96–102.
175. Griffin WS, Mrak RE, Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease, J Leukoc Biol, 2002;72:233–8.
176. Griffin WS, Yeralan O, Sheng JG, et al., Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy, J Neurochem, 1995;65:228–33.
177. Sheng JG, Boop FA, Mrak RE, Griffin WS, Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity, J Neurochem, 1994;63: 1872–79.
178. Wisniewski TL, Mendel E, Morse EV, et al., Relationship between serum cyclo(His-Pro) concentrations and the nutritional status of HIV-infected patients, South Med J, 1994;87:348–51.
US NEUROLOGY
27
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132